Short Communication on: Study of Avidity of Antigen-Specific Antibody as a Means of Understanding Development of Long-Term Immunological Memory after Vibrio cholerae O1 Infection
Journal Title: UNKNOWN - Year 2017, Vol 8, Issue 4
Abstract
Interaction between antigen and antibody modulates key biological processes in neutralizing and eliminating pathogenic microorganisms following infection. The strength of this interaction depends on the affinity, valency and three dimensional arrangements of the interacting epitopes and paratopes. The measure of the overall strength of this multimeric interaction is termed as ‘Avidity’. Development of antibody with high avidity is a crucial feature of a secondary immune response followed by a low avidity antibody producing primary response [1,2]. Thus antibody avidity has been used as a marker for B cell maturation and is an important surrogate for determining long term immunological memory responses to pathogens. In our article entitled “Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory afterVibrio choleraeO1 infection” we showed that antibody avidity after infection and immunization is a good correlate of the development and maintenance of memory B cell responses to V. cholerae O1 antigens. To the best of our knowledge this is the first study that assesses antibody avidity following a non-invasive mucosal infection [3].
Authors and Affiliations
Mohammad Murshid Alam, Taufiqur Rahman Bhuiyan, Firdausi Qadri
Keywords
Related Articles
- EP ID EP363342
- DOI 10.4172/2157-7560.1000363
- Views 21
- Downloads 0
Changes of Antibody Associated with Cell-Mediated Immunity in College Students During Two Years after Rubella Vaccination
Objective: This study measured cell-mediated immunity (CMI) and serum antibody levels against rubella to clarify antibody changes associated with CMI during 2 years after vaccination. Methods: The study subjects were 64...
Immune Response Modifying Effects of Bee Venom Protein [Melittin]/Autoclaved L. donovani complex in CD1 Mice: The Search for New Vaccine Adjuvants
Visceral leishmaniasis (VL) is a major cause of morbidity/mortality in remote areas of East Africa. Vaccines for VL can provide an effective control measure to help control/eliminate this fatal disease. To date there is...
Simplified Pneumococcal Vaccination Schedules for Adults Age 50 and Over Lead to Worse Health
Background: In 2014 the Advisory Committee on Immunization Practices (ACIP) approved a dose of 13-valent pneumococcal conjugate vaccine (PCV13) for all adults at age 65 years. This further complicated the pneumococcal va...
Evaluation of an Experimental Vaccine for Atrophic Rhinitis in Piglets
Background: Commercial swine atrophic rhinitis (AR) vaccine contains killed Bordetella bronchiseptica and P. multocida toxin (PMT) from Toxigenic Pasteurella multocida. The recombinant PMT proteins used as vaccine candid...
Age to End Dreadful Diseases (HIV, Malaria, TB, Cancer and More): A Theory of Intact or Protected Complement (IPC) Immunity
After enormous efforts to fight for a successful HIV vaccine, the movement ended with frustration. While people are celebrating the victories of disease prophylaxis and healthy improvement, millions of them are still str...